Rectal Cancer Clinical Trial
Official title:
Community Dissemination of an Evidence-based CRC Screening Intervention
Filipino Americans have lower rates of colorectal cancer (CRC) screening, later stage of
diagnosis and poorer survival relative to other racial/ethnic groups. To address this
disparity, the investigators developed a multi-component intervention to increase CRC
screening and have determined its efficacy in a randomized trial (Maxwell,et. al., 2010).
This study aims to determine how an intervention to increase CRC screening can best be
integrated within the cultural norms and existing structures of churches and community based
organizations (CBOs) with predominantly Filipino American membership to ensure broad
dissemination to those in need of screening.
The investigators will provide our partner CBOs with resources and technical assistance,
including training of community volunteers as health advisors, to enable them to promote CRC
screening to their constituents. Using a scientifically rigorous research design, the
investigators will compare two dissemination strategies: Basic dissemination which consists
of a single kick-off event during which community health advisors will receive print
materials and FOBT kits for distribution and training on how to conduct educational
small-group sessions; and Organizational dissemination aimed at integrating CRC screening
dissemination into organizational practices and processes that can be sustained after the
end of the study. The study will be implemented in 20 CBOs and will train 100 community
health advisors (CHAs). The impact of the two dissemination strategies will be
comprehensively assessed by collecting data at the CBO level, from the CHAs and from 1000
Filipino American participants. The investigators will compare the proportion of Filipino
American participants who obtain CRC screening by dissemination strategy, but the
investigators will also assess how many are reached, if the intervention is implemented as
planned, how CBOs support the screening efforts at their regular activities, and if CBOs and
CHAs maintain their efforts over the 4 years of the study.
The investigators hypothesize that CBOs can implement evidence-based strategies to promote
CRC screening and CHAs in the organizational dissemination arm will reach more participants
and more screened participants than CHAs in the basic dissemination arm; and organizations
in the organizational dissemination arm will adopt more CRC screening activities and
maintain these better than organizations in the basic dissemination arm.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Screening
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06380101 -
Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
|
N/A | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Recruiting |
NCT04323722 -
Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04088955 -
A Digimed Oncology PharmacoTherapy Registry
|
||
| Active, not recruiting |
NCT01347697 -
Collagen Implant (Biological Mesh) Versus GM Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer
|
N/A | |
| Recruiting |
NCT04495088 -
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
|
Phase 3 | |
| Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
| Terminated |
NCT01347645 -
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT03520088 -
PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS
|
N/A | |
| Recruiting |
NCT05556473 -
F-Tryptophan PET/CT in Human Cancers
|
Phase 1 | |
| Recruiting |
NCT04749381 -
The Role of TCM on ERAS of Rectal Cancer Patients
|
Phase 2 | |
| Enrolling by invitation |
NCT05028192 -
Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
|
||
| Recruiting |
NCT03283540 -
Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
|
||
| Completed |
NCT04534309 -
Behavioral Weight Loss Program for Cancer Survivors in Maryland
|
N/A | |
| Recruiting |
NCT05914766 -
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
|
N/A | |
| Recruiting |
NCT04852653 -
A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
|
||
| Recruiting |
NCT03190941 -
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
|
Phase 1/Phase 2 | |
| Completed |
NCT02810652 -
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
|
N/A | |
| Terminated |
NCT02933944 -
Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer
|
Phase 1 |